FDA Launches Call Center To Simplify Expanded Access For Cancer Drugs

FDA on Monday (June 3) announced a pilot program call center at its oncology office that is meant to serve as an information hub for physicians treating patients with cancer who seek access to unapproved therapies. The agency hopes the center, called Project Facilitate, will streamline the Expanded Access request process for physicians, provide patients with new therapies, and provide data that FDA hopes could assist sponsors to open clinical trials for additional uses of existing drugs. The Expanded Access...